The article discusses how wealthier adults in England have significantly increased the demand for ADHD medications, with prescriptions growing twice as fast for the least deprived 20% of the population as for the most deprived, from May 2020 to September 2023. This surge in demand comes amid global medication shortages and is partly attributed to quicker access to diagnosis and treatment through private services. The NHS faces challenges in meeting this demand, with some waiting times exceeding 10 years. The article also touches on the broader issue of ADHD underdiagnosis in the UK and the effective treatment of ADHD as an economically wise investment​
You can read the full article here: https://www.ft.com/content/eb2fac42-e95d-4487-a270-1a7bc5f7d5f4
